|
Article Excerpt
NASD--AMLN
Amylin Pharmaceuticals, Inc. is a biopharmaceutical company that develops medicines to improve the lives of people with metabolic diseases. The company's two late-stage, first-in-class diabetes product candidates--SYMLIN[R] (pramlintide acetate) and exenatide (synthetic exendin-4)--are being developed to address diabetes. Amylin has a strategic alliance with Eli Lilly and Co. for the co-development and global commercialization of exenatide, and an extended release formulation, exenatide LAR. Building on its experience in the diabetes field, the company is also developing candidates for cardiovascular disease and obesity by utilizing its research experience with the metabolic properties common to all three conditions.
Value Total number of shares outstanding as of July 21, 2003 92,800,000 Price of each share of common stock on July 21, 2003 $23.26 Aggregate market value as of July 21, 2003 $2,158,528,000 Performance Record For year ended Dec. 31, in thousands, except per-share data 2002 2001 2000 Net income (loss) $(109,787) $(71,972) $(44,043) Net income (loss) per share $(1.39) $(1.09) $(0.71) Total assets $168,545 63,527 $90,635
Directors
Joseph C. Cook,...
|
|
More articles from San Diego Business Journal
Historic building faces reincarnation as condos: home sales falter in ..., July 28, 2003
Progress report.(Real Estate), July 28, 2003
Construction journal.(Real Estate)(Bilbro Construction Co.'s 1,200-squ..., July 28, 2003
Metropolitan water agency debuts minority biz program: USD event offer..., July 28, 2003
Small business.(Spotlight), July 28, 2003
Looking for additional articles?
Search our database of over 3 million articles.
Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication
name or publication date.
About Goliath
Whether you're looking for sales prospects, competitive information, company
analysis or best practices in managing your organization,
Goliath can help you meet your business needs.
Our extensive business information databases empower business
professionals with both the breadth and depth of credible,
authoritative information they need to support their business
goals. Whether it be strategic planning, sales prospecting,
company research or defining management best practices -
Goliath is your leading source for accurate information.
|
|
